Concepedia

Alen Ostojić

AO

10

Publications

245

Citations

10

H-Index

2011

Active since

Affiliations

University Hospital Centre Zagreb(Current)

University of Zagreb

National Cancer Institute

National Institutes of Health

Center for Cancer Research

Alen Ostojić is an author at University Hospital Centre Zagreb specializing in hematology, medicine, and immunology.

ORCID

Top concepts

Publications per year

2011–2021

10

Publications

10

Ruxolitinib: A New JAK1/2 Inhibitor That Offers Promising Options for Treatment of Myelofibrosis

Alen Ostojić, Radovan Vrḫovac, Srđan Verstovšek · Future Oncology · 2011 · 72 citations · Full text

, , +20

Ruxolitinib for the treatment of myelofibrosis: its clinical potential

Srdan Verstovsek, Alen Ostojić, Vrhovac et al. · Therapeutics and Clinical Risk Management · 2012 · 51 citations · Full text

Early human cytomegalovirus reactivation is associated with lower incidence of relapse of myeloproliferative disorders after allogeneic hematopoietic stem cell transplantation

Zinaida Perić, Jonas Wilson, Nadira Duraković et al. · Bone Marrow Transplantation · 2018 · 33 citations · Full text

, , +10

A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease

Lauren M. Curtis, Alen Ostojić, David Venzon et al. · Blood · 2020 · 20 citations · Full text

Efficacy and Safety of Baricitinib in Refractory Chronic Graft-Versus-Host Disease (cGVHD): Preliminary Analysis Results of a Phase 1/2 Study

Noa G. Holtzman, Annie Im, Alen Ostojić et al. · Blood · 2020 · 15 citations

Rows per page

1–5 of 10